Browsing HLS Student Papers by Title
Now showing items 378-397 of 498
-
The Real Fountain of Youth: How Old Drugs Get Covered By New Patents
(2003)Until 1995, the term of a patent was 17 years from issue, with a possible extension of five years for delays in market entry related to the Food and Drug Administration drug approval process. Still, many pharmaceutical ... -
The Real Thalidomide Baby: The Evolution of the FDA in the Shadow of Thalidomide, 1960-1997
(1997)This paper is intended to document the over thirty-year relationship between the FDA and thalidomide and to describe in some detail the new uses for that drug. The paper’s secondary goal is to demonstrate ... -
Reaping the Full Health Benefits of the Human Genome: The Duty to Warn and The Need to Establish a Comprehensive Federal Regulatory Structure for Genetic Testing
(2002)This paper discusses the need for a comprehensive federal regulatory structure governing genetic testing. Particularly, the article proposes a legal standard to govern physicians’ duty to warn their ... -
Reassessing Pre-market Regulation of Class III Medical Devices
(2003)Regulation of medical devices has evolved over the past twenty-five years. Initially, Congress created a regime where the safety and efficacy of all medical devices would be reviewed to varying degrees, depending on the ... -
Reconsidering Caffeine: An Awake and Alert New Look at America's Most Commonly Consumed Drug
(2004)Caffeine is one of the most pervasively ingested addictive substances in the United States, yet astoundingly little attention is paid to its ubiquitous presence. This Paper examines caffeine, the substance, from many ... -
Reducing Obesity and Fostering Economic Development Through Farm to School: Analysis and Recommended Actions
(2014-03-18)Using Mississippi as a case study, this paper describes the potential for expanding farm to school and provides recommendations for state and local actions to encourage its growth. Part I provides a brief background of ... -
Reexamining Food Labels: A Proposal for Labeling Environmental Information on Food Products
(2001)Since at least 1938, Congress has been concerned with informing the public as consumers about the food products they purchase. During 1938, Congress passed the Food, Drug & Cosmetic Act which required that manufacturers ... -
REFORMING DRUG APPROVAL IN THE UNITED STATES: MEASURES NECESSARY TO ALLEVIATE THE CASH CRUNCH FACED BY SMALL BIOTECHNOLOGY COMPANIES
(1995)Over the past decade, the infant biotechnology industry, led by small biotechnology companies, has produced numerous breakthrough drugs which have saved lives, reduced suffering and cut the cost of health care. Given that ... -
Regulate This: The Politics and Practice of Poo Farming
(2006)This paper will look at the use and regulation of biosolids on farmland in America. I will detail the history behind biosolids and its utilization as fertilizer. I will also examine the scant legislative oversight over ... -
Regulating Agri-Biotechnology through Information: The European Union and its System for Labeling Foods Containing, Consisting of, & Produced From Genetically Modified Organisms
(2005)There are few issues more controversial in the European Union than the use of genetically modified organisms (GMOs) in the food production chain. The original intent of the EU’s GM food regulations was ... -
Regulating Cochlear Implants: The Legal Response to a Scientific and Cultural Revolution
(2003)This paper is a case study on the cochlear implant device. The inquiry will explore the important aspects of the device's intended use, its legal regulation, and its moral impact. Through this case study I hope to illustrate ... -
Regulating Food and Drug Companies Privately: A View of Lanham Act Cases Brought Against FDA-Regulated Products
(2001)The Lanham Act provides a flexible self-help remedy to food and drug companies that are harmed by unfair competition in the marketplace. But is it desirable for private litigation to become the de facto regulation of the ... -
Regulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration
(1999)Despite the growth of both the use of homeopathic drugs and the homeopathic drug industry, the Food and Drug Administration (FDA) has not altered its regulatory scheme for homeopathic drugs. As a result, homeopathic drugs ... -
REGULATING MAMMOGRAMS
(1998)Mammography is widely used as a cancer detection device; unfortunately, it is often misused or performed inadequately. The need for proper supervision and regulation is of a concern to every woman. -
Regulating the Export of Unapproved Drugs
(1995)Prior to 1986, it was not possible under the Federal Food Drug and Cosmetics Act to export drugs which did not have FDA approval. The law was changed by the Drug Export Amendments Act of 1986 after nearly a decade of debate. ... -
Regulating Transgenic "Pharm" Plants: Pre-Commercialization Review and Post-Commercialization Monitoring
(2004)This manuscript presents an analysis of the regulation of transgenic plants that are engineered to express pharmaceutical or industrial products (referred to throughout as “pharm†plants). ... -
The Regulation of Animal Welfare in Food Production
(2005)This paper surveys the various ways in which we choose to regulate, or could choose to regulate, the treatment of animals in food production. “Regulation†is broadly defined to encompass any ... -
The Regulation of Drug Manufacturing Changes: Past, Present and Foreign
(1997)This paper examines the history of FDA regulation of manufacturing supplements for drugs, summarizes the current equivalent regulations of the European Union (EU), and concludes by discussing some current proposals for ... -
Regulation of Fat Content in Food: Recent History and Cultural Commentary
(2006)Fat content in food has been one of the most hotly contested areas of nutrition labeling. This paper traces the changes in fat content labeling requirements for packaged food from the optional disclosure system in place ... -
Regulation of Genetically Engineered Food Products: A Market-Oriented Perspective
(1995)Only twenty years after the landmark Asilomar meeting where scientists discussed the opportunities and possible risks presented by the ability to transfer DNA from one organism to another,' bioengineered products have moved ...